摘要
Abstract
Objective: To investigate the clinical efficacy and adverse reactions of cefoperazone sulbac-tam sodium in the treatment of community-acquired pneumonia. Method: 76 cases of community-acquired pneumonia were randomly divided into study group and control group, 38 cases in each group, both groups were given community-acquired pneumonia conventional treatment, the control group were given levofloxacin 200mg , intravenous infusion, 5 to 7 days for a course. The study group were given cefoperazone sulbactam 2g, intravenous infusion, twice daily, 5 to 7 days. Result: The body temperature in the study group returned to normal time ( 16. 5 ± 1.3 ) h, the total effective rate was 97. 4% ( 37/38 ); control group, body temperature returned to normal time ( 28. 5 ± 1. 5 ) h, the total effective rate was 81.6% ( 31 /38 ), ( P < 0. 05 ); study group of adverse reactions was 7. 9% ,the incidence of adverse in the control group was 10. 5% , ( P> 0. 05 ). Conclusion: The clinical efficacy of cefoperazone sulbactam sodium treatment of community-acquired pneumonia is better, adverse reactions is less, worthy of clinical application.关键词
社区获得性肺炎/头孢哌酮舒巴坦钠/左氧氟沙星Key words
Community-acquired pneumonia/ Cefoperazone sulbactam/ Levofloxacin
